C
Registered Attendees
Jane Acri
National Institute on Drug Abuse
Andrew Ahn
Eli Lilly and Company
Seun Ajiboye
American Association for Dental Research
Seena Ajit
Drexel University College of Medicine
Mohammed Akbar
National Institute on Alcohol Abuse and Alcoholism
Susan Amara
National Institute of Mental Health
Rachel Anderson
American Association for the Advancement of Science
Angela Arensdorf
National Center for Complementary and Integrative Care
Shilli Avenevoli
National Institute of Mental Health
Susan Awad
American Society of Addiction Medicine
Lisa Bain
Lisa Bain, LLC
Rita Balice-Gordon
Sanofi, Inc.
Inna Belfer
National Institutes of Health
Christina Berry
ADVI Health, LLC
Ellen Blackwell
Centers for Medicare & Medicaid Services
Lizbet Boroughs
Association of American Universities
Richard Boyce
Veterans Affairs Medical Center
Maureen Boyle
National Institute on Drug Abuse
Josephine Briggs
National Center for Complementary and Integrative Health
Katja Brose
Chan Zuckerberg Initiative
Emery Brown
Massachusetts Institute of Technology
Dorothy Brown
Eli Lilly and Company – Elanco
Michael Brown
GE Global Research
Sarah Caddick
Gatsby Charitable Foundation
Erin Cadwalader
Lewis-Burke Associates
Brian Campbell
MindImmune Therapeutics
Rosa Canet-Aviles
Foundation for the National Institutes of Health
Jooyoung Cha
Department of Health and Human Services
Timothy Coetzee
National Multiple Sclerosis Society
Jonathan Cohen
Princeton University
Wilson Compton
National Institute on Drug Abuse
Roger Crystal
Opiant Pharmaceuticals
Marc Cuesta
Brain Canada
Katherine Dawson
Biogen
Joan Demetriades
One Mind
Luda Diatchenko
McGill University
E. Ray Dorsey
University of Rochester
Martin Duenas
Leidos
John Dunlop
Amgen
Robert Dworkin
University of Rochester School of Medicine
Emmeline Edwards
National Center for Complementary and Integrative Health
Mark Egli
National Institute on Alcohol Abuse and Alcoholism
Anne Esposito
Indivior, Inc.
Dorothy Farrell
American Association of Colleges of Pharmacy
Christopher Flores
Johnson & Johnson Consumer, Inc.
Danielle Friend
BIO
Crina Frincu
National Institute of Dental and Craniofacial Research
Gary Fujii
Molecular Express, Inc.
Brendon Gehrke
Department of Veterans Affairs
Robert Gereau
Washington University School of Medicine
Joshua Gordon
National Institute of Mental Health
Christopher Gorini
Food and Drug Administration
Magali Haas
Cohen Veterans Bioscience
Tariq Habib
Alkarim Traders International
Mohamed Hachicha
National Institute of Neurological Disorders and Stroke
Bruce Hammock
EicOsis Human Health
Dean Hartley
Alzheimer’s Association
Christian Heidbreder
Indivior, Inc.
Laura Helbling
The RPM Report
Sharon Hertz
Food and Drug Administration
Tom Hill
National Council for Behavioral Health
Carrie Hill
National Sheriffs Association
Sam On Ho
Molecular Express, Inc.
Richard Hodes
National Institute on Aging
Stuart Hoffman
Department of Veterans Affairs
Steven Hyman
Broad Institute of Massachusetts Institute of Technology and Harvard University
Michael Irizarry
Eli Lilly and Company
Inez Jabalpurwala
Brain Canada
Abdulmajeed Jali
Virginia Commonwealth University
Jori Kandra
University of Texas System
Petra Kaufmann
National Center for Advancing Translational Sciences
John Kehne
National Institute of Neurological Disorders and Stroke
Andrew Kessler
Slingshot Solutions
Mary Beth Kester
National Center for Complementary and Integrative Health
Partap Khalsa
National Center for Complementary and Integrative Health
Shannon Kirkland
National Education Association
Brian Klein
National Institute of Neurological Disorders and Stroke
Walter Koroshetz
National Institute of Neurological Disorders and Stroke
Elena Koustova
National Institute on Drug Abuse
Alexander Kraus
Self-Employed
Audrey Kusiak
Department of Veterans Affairs
Deep Kwatra
Food and Drug Administration
Pascal Laeng
National Institute of Neurological Disorders and Stroke
Vanessa Lamers
Public Health Foundation
Story Landis
National Institute of Neurological Disorders and Stroke (emeritus)
Deborah Leiderman
CNS Drug Consulting, LLC
Shari Ling
Centers for Medicare & Medicaid Services
Sean Mackey
Stanford School of Medicine
William Maixner
Duke University
Ronald Marcus
Cerecor
Sopio Mataradze
DAC
David McCann
National Institute on Drug Abuse
Owen McManus
Q-State Biosciences
Abdeljalil Mekkaoui
Self-Employed
David Michelson
Merck
Ivan Montoya
National Institute on Drug Abuse
Grace Moser
Prevision Policy, LLC
Chris Naso
Community Anti-Drug Coalition of America
Mei-Hing Ng
Tsaotun Psychiatric Center, Taiwan
Jessica Hulsey Nickel
Addiction Policy Forum
Kathy Orellana
American Psychiatric Association
Andrey Ostrovsky
Center for Medicaid and CHIP Services
Bryan Parker
International Healthcare
Julia Pinto
Food and Drug Administration
Leah Pog
National Institute of Neurological Disorders and Stroke
Linda Porter
National Institute of Neurological Disorders and Stroke
Scott Powers
Cincinnati Children’s Hospital Medical Center; University of Cincinnati College of Medicine
Theodore Price
The University of Texas at Dallas
Khara Ramos
National Institute of Neurological Disorders and Stroke
Beeta Rasouli
Lewis-Burke Associates
Soundar Regunathan
National Institute on Alcohol Abuse and Alcoholism
Alicia Richmond Scott
Department of Health and Human Services
Carol Robertson-Plouch
Biopharmaceutical Advisors and Consultants
Becky Roof
National Institute of Nursing Research
Tarek Samad
Pfizer Inc.
Friedhelm Sandbrink
Veterans Health Administration
Cheryse Sankar
National Institute of Neurological Disorders and Stroke
Eugenia Schenecker
The George Washington University
Richard Schottenfeld
Howard University College of Medicine
Nikki Semenza
Community Anti-Drug Coalition
Marilyn Serafini
Health Policy Translation
Danielle Shapiro
National Center for Health Research
Robert Shibuya
Food and Drug Administration
David Shurtleff
National Center for Complementary and Integrative Medicine
Lily Silayeva
The Tauri Group
Christopher Spevak
Walter Reed National Military Medical Center
Jack Stein
National Institute on Drug Abuse
Jim Sullivan
AbbVie, Inc.
Margaret Sutherland
National Institute of Neurological Disorders and Stroke
Edmund Talley
National Institute of Neurological Disorders and Stroke
Amir Tamiz
National Institute of Neurological Disorders and Stroke
Wendy Toler
Consultant
Drew Townsend
Virginia Commonwealth University
Yoland Vallejo
National Institute of Dental and Craniofacial Research
Christin Veasley
Chronic Pain Research Alliance
Kenneth Verburg
Pfizer Inc.
Nora Volkow
National Institute on Drug Abuse
Tor Wager
University of Colorado Boulder
Sharon Walsh
University of Kentucky
Ashley Walton
American Society of Anesthesiologists
Jacqueline Ward
National Institute of Neurological Disorders and Stroke
Lynn Webster
PRA Health Sciences
Andrew Welchman
Wellcome Trust
Cole Werble
Prevision Policy, LLC
David White
National Institute on Drug Abuse
Clifford Woolf
Boston Children’s Hospital; Harvard Medical School
Nicole Wrigley
SeekHealing
Tony Yaksh
University of California, San Diego
Stevin Zorn
The University of Rhode Island; MindImmune Therapeutics, Inc.
